Clinical trial
Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
NCT04349566 is registered in ClinicalTrials.gov with Mads Peter Godtfeldt Stemmerik as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
- Lead sponsor
- Mads Peter Godtfeldt Stemmerik
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2020
- Completion date
- December 20, 2021
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
becker muscular dystrophy, limb-girdle muscular dystrophy type 2, mcardle disease